Children are not just small adults. Drugs work differently in children and must be studied specifically for their use. Yet too often, drug development still leaves children behind. The Innovation in Pediatric Drugs Act of 2023, H.R. 6664, sponsored by Rep. Anna Eshoo (D-Calif.) and Rep. Mike McCaul (R-Texas), will help speed therapies to children who need them by making needed changes to the pediatric drug laws. This bill gives the FDA the authority it needs to ensure that legally required pediatric studies are completed in a timely way. Currently, they can only do this in drugs for adult studies.

We ask you to reach out to your Representative to seek their cosponsorship of this important bill.